European and US guideline-based statin eligibility, genetically predicted coronary artery disease, and the risk of major coronary events.

28 August 2023 (11:15 - 11:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Hanjin Park

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail

An in vitro investigation of the effects of Urolithins A and B on low-density lipoprotein uptake and its regulatory genes.

Professor M. Banach (Lodz, PL)

Abstract Slides Video

Presentation thumbnail

The determinant role of high-density lipoprotein cholesterol on the recovery of left ventricle ejection fraction after acute coronary syndromes

Doctor A. Cordero (Alicante, ES)

Abstract Slides

Presentation thumbnail

Atherogenic lipid profile in patients with acute coronary syndrome

Doctor J. Yang (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

Guideline-directed low-density lipoprotein cholesterol management following acute ischemic stroke: findings from Clalit health services

Doctor A. Aker (Haifa, IL)

Abstract Slides Video

Presentation thumbnail

Low-density-lipoprotein cholesterol target attainment in high-risk patients with history of diabetes or major adverse cardiac and cerebrovascular event: an (un)expected gender bias

Professor R. Marcucci (Florence, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Risk factors and prevention: lipids (4)

The Event

Event poster

ESC Congress 2023

28 August 2023 11:15 CET

You may be interested in

Congress Presentation

Polygenic risk scoring for coronary artery disease (CAD) - current data

Congress Presentation

Genetic scores are the future of personalised lipid-lowering

Congress Presentation

Do genetic scores help risk stratify in primary prevention?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources